Jersey City, NJ (PRWEB) November 13, 2014 -- Viora, a leading medical aesthetics solutions provider, announces the appointment of Michael Botvinick, as Sales Director for the Southwest Region. A veteran with over 16 years of experience in the medical aesthetics industry, including the successful launch of several products and companies, Mr. Botvinick will be a strong asset in the company’s growth.
Before joining Viora, Mr. Botvinick held a management position at Candela/Syneron and was instrumental in launching the Vbeam®, elōs Plus platform and VelaShape III, as well as directing all sales and business development efforts. He also held management positions with Alma Lasers and Zeltiq, where he was responsible for growth and awareness in his region by opening reference sites and producing published papers.
“Michael is one of the best leaders in the industry and we are honored to have him on our leadership team supporting Viora in this exciting growth period,” said Eliran Almog, Viora CEO. “His knowledge of multi-technology platforms will be instrumental to Viora’s successful launch of its new V-Series platforms.”
“Viora is at a wonderful stage right now,” Botvinick said. “I haven’t been this excited for a long time and I’m looking forward to working with this Viora team.”
About Viora
Viora is an award-winning medical aesthetics solutions company that’s established in over 65 countries. Viora’s skilled and knowledgeable clinical and technical teams, working with clinicians around the world, have produced innovative, proprietary technologies such as CORE™, SVC™ and PCR™. These technologies have revolutionized non-invasive treatments to improve control and increase opportunity for practitioners, while enhancing the patient experience. In addition, this in-house expertise has been at the forefront of implementing new developments in response to market demand, improving upon treatments using existing technologies such as laser and IPL.
Lisa Appelson, VIORA, http://www.vioramed.com/, +1 (201) 332-4100 Ext: 104, [email protected]
Share this article